These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
142 related articles for article (PubMed ID: 8228723)
21. Should stimulation therapy for congestive heart failure be combined with defibrillation backup? Gaita F; Bocchiardo M; Porciani MC; Vivalda L; Colella A; Di Donna P; Caponi D; Bruzzone M; Padeletti L Am J Cardiol; 2000 Nov; 86(9A):165K-158K. PubMed ID: 11084118 [TBL] [Abstract][Full Text] [Related]
22. Symptomatic conduction system disease in cardiac amyloidosis. Mathew V; Olson LJ; Gertz MA; Hayes DL Am J Cardiol; 1997 Dec; 80(11):1491-2. PubMed ID: 9399732 [TBL] [Abstract][Full Text] [Related]
23. Reduced risk for inappropriate implantable cardioverter-defibrillator shocks with dual-chamber therapy compared with single-chamber therapy: results of the randomized OPTION study. Kolb C; Sturmer M; Sick P; Reif S; Davy JM; Molon G; Schwab JO; Mantovani G; Dan D; Lennerz C; Borri-Brunetto A; Babuty D JACC Heart Fail; 2014 Dec; 2(6):611-9. PubMed ID: 25282033 [TBL] [Abstract][Full Text] [Related]
24. [The pacemaker and implantable cardioverter-defibrillator registry of the Italian Association Arrhythmology Cardiac Pacing and cardiac pacing - annual report 2013]. Proclemer A; Zecchin M; D'Onofrio A; Botto GL; Rebellato L; Ghidina M; Bianco G; Bernardelli E; Pucher E; Gregori D G Ital Cardiol (Rome); 2014 Nov; 15(11):638-50. PubMed ID: 25424143 [TBL] [Abstract][Full Text] [Related]
25. The Jervell and Lange-Nielsen syndrome; atrial pacing combined with ß-blocker therapy, a favorable approach in young high-risk patients with long QT syndrome? Früh A; Siem G; Holmström H; Døhlen G; Haugaa KH Heart Rhythm; 2016 Nov; 13(11):2186-2192. PubMed ID: 27451284 [TBL] [Abstract][Full Text] [Related]
26. Complications of permanent cardiac pacing in patients with persistent left superior vena cava. Polewczyk A; Kutarski A; Czekajska-Chehab E; Adamczyk P; Boczar K; Polewczyk M; Janion M Cardiol J; 2014; 21(2):128-37. PubMed ID: 24526508 [TBL] [Abstract][Full Text] [Related]
27. Spectrum of issues detected by an ICD diagnostic alert that utilizes far-field electrograms: Clinical implications. Koneru JN; Kaszala K; Bordachar P; Shehata M; Swerdlow C; Ellenbogen KA Heart Rhythm; 2015 May; 12(5):957-67. PubMed ID: 25640632 [TBL] [Abstract][Full Text] [Related]
29. [The Pacemaker and Implantable Cardioverter-Defibrillator Registry of the Italian Association of Arrhythmology and Cardiac Pacing - Annual report 2015]. Proclemer A; Zecchin M; D'Onofrio A; Boriani G; Botto GL; Facchin D; Rebellato L; Ghidina M; Bianco G; Bernardelli E; Pucher E; Gregori D G Ital Cardiol (Rome); 2017 Jan; 18(1):67-79. PubMed ID: 28287212 [TBL] [Abstract][Full Text] [Related]
30. Survival after shock therapy in implantable cardioverter-defibrillator and cardiac resynchronization therapy-defibrillator recipients according to rhythm shocked. The ALTITUDE survival by rhythm study. Powell BD; Saxon LA; Boehmer JP; Day JD; Gilliam FR; Heidenreich PA; Jones PW; Rousseau MJ; Hayes DL J Am Coll Cardiol; 2013 Oct; 62(18):1674-1679. PubMed ID: 23810882 [TBL] [Abstract][Full Text] [Related]
31. The implantable cardioverter defibrillator. Glikson M; Friedman PA Lancet; 2001 Apr; 357(9262):1107-17. PubMed ID: 11297981 [TBL] [Abstract][Full Text] [Related]
32. Multiple shocks after upgrade of an implantable cardioverter-defibrillator to a cardiac resynchronization therapy-defibrillator device. Francisco GM; Sharma S; Dougherty AH; Kantharia BK Cardiol J; 2009; 16(5):473-6. PubMed ID: 19753529 [TBL] [Abstract][Full Text] [Related]
33. Pacemaker-induced inappropriate implantable cardioverter-defibrillator shock: an unusual case of arrhythmia induction. Anderson DR; Fletcher D; Scherschel JA; Easley AR Heart Rhythm; 2011 Feb; 8(2):328-30. PubMed ID: 20887806 [No Abstract] [Full Text] [Related]
34. The DATAS rationale and design: a controlled, randomized trial to assess the clinical benefit of dual chamber (DDED) defibrillator. Quesada A; Almendral J; Arribas F; Ricci R; Wolpert C; Adragao P; Cobo E; Navarro X; Europace; 2004 Mar; 6(2):142-50. PubMed ID: 15018874 [TBL] [Abstract][Full Text] [Related]
35. Antiarrhythmic drugs in patients with implantable cardioverter-defibrillators. Bollmann A; Husser D; Cannom DS Am J Cardiovasc Drugs; 2005; 5(6):371-8. PubMed ID: 16259525 [TBL] [Abstract][Full Text] [Related]
37. Case report: Delayed detection of ventricular tachycardia due to intradevice interactions by implantable atrio-ventricular pacer/cardioverter defibrillator. Kantharia BK; Padder FA J Interv Card Electrophysiol; 2006 Aug; 16(2):135-8. PubMed ID: 17016683 [TBL] [Abstract][Full Text] [Related]
38. Use of an electrocardiographic screening tool to determine candidacy for a subcutaneous implantable cardioverter-defibrillator. Groh CA; Sharma S; Pelchovitz DJ; Bhave PD; Rhyner J; Verma N; Arora R; Chicos AB; Kim SS; Lin AC; Passman RS; Knight BP Heart Rhythm; 2014 Aug; 11(8):1361-6. PubMed ID: 24755323 [TBL] [Abstract][Full Text] [Related]
39. Results of the international study of the implantable pacemaker cardioverter-defibrillator. A comparison of epicardial and endocardial lead systems. The Pacemaker-Cardioverter-Defibrillator Investigators. Zipes DP; Roberts D Circulation; 1995 Jul; 92(1):59-65. PubMed ID: 7788918 [TBL] [Abstract][Full Text] [Related]
40. Implantable dual-chamber cardioverter-defibrillator-pacemaker. Pfeiffer D; Mende M; Hagendorff A Curr Cardiol Rep; 2000 Jul; 2(4):335-40. PubMed ID: 10953268 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]